Ann: Botanix Joins with UQ to Accelerate Development of BTX 1801, page-5

Awesome indeed and it accelerates considerations for BTX1801 as a promising new antibiotic:

​

Botanix awarded Innovation Connections Grant from the Australian Government and forms research collaboration with UQ’s Institute for Molecular Bioscience
• Research collaboration to further explore the antimicrobial activity of cannabidiol and PermetrexTM skin delivery technology
• Botanix is developing BTX 1801, a novel antimicrobial with the potential to address unmet needs in serious skin infections with significant market opportunities
• Studies facilitate the identification of the preferred type of skin infection to target for BTX 1801 in preparation for clinical studies targeted for 4Q CY2018

​

"We are also very pleased that the potential of BTX 1801 has been supported by AusIndustry through the Innovation Connection Grant program. This demonstrates Botanix’s ability to secure non-dilutive funding to progress its product pipeline in parallel to the development of its lead acne and atopic dermatitis products."
The research collaboration will include an assessment of the impact of BTX 1801 against a diverse panel of antibiotic resistant organisms and more than 100 clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Staphylococcus aureus are a common cause of skin infections, such as Acute Bacterial Skin and Skin Structure Infections (ABSSSI). This research forms a critical part in establishing which skin infection Botanix will target first.

In the US alone, more than 3 million patients are hospitalised each year, which in combination with outpatients, leads to an estimated 30 million days of treatment and comprises a market worth approximately US$10bn1.
Dr. Mark Blaskovich, Principal Investigator and Program Coordinator at IMB said: "We welcome this opportunity to work in collaboration with Botanix to investigate the antimicrobial properties of BTX 1801. Antibiotic resistance is a significant global concern and we are excited about the potential prospects of BTX 1801 in this field. The partnership is also testament to the university engaging with industry to embed research discovery into the problem-solving process, so together we can bring solutions to market more quickly and with greater impact."